294 related articles for article (PubMed ID: 12393901)
41. Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities.
Jang YJ; Park KS; Chung HY; Kim HI
Cancer Lett; 2003 May; 194(1):107-17. PubMed ID: 12706864
[TBL] [Abstract][Full Text] [Related]
42. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
[TBL] [Abstract][Full Text] [Related]
44. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver.
Rüdiger HA; Clavien PA
Gastroenterology; 2002 Jan; 122(1):202-10. PubMed ID: 11781294
[TBL] [Abstract][Full Text] [Related]
45. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
46. Caspase-1 mediates Fas-induced apoptosis and is up-regulated by interferon-gamma in human astrocytoma cells.
Choi C; Jeong E; Benveniste EN
J Neurooncol; 2004; 67(1-2):167-76. PubMed ID: 15072464
[TBL] [Abstract][Full Text] [Related]
47. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
48. Tumor necrosis factor α sensitizes primary murine hepatocytes to Fas/CD95-induced apoptosis in a Bim- and Bid-dependent manner.
Schmich K; Schlatter R; Corazza N; Sá Ferreira K; Ederer M; Brunner T; Borner C; Merfort I
Hepatology; 2011 Jan; 53(1):282-92. PubMed ID: 20872776
[TBL] [Abstract][Full Text] [Related]
49. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
[TBL] [Abstract][Full Text] [Related]
50. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
51. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
[TBL] [Abstract][Full Text] [Related]
52. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
[TBL] [Abstract][Full Text] [Related]
53. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis.
Kothny-Wilkes G; Kulms D; Luger TA; Kubin M; Schwarz T
J Biol Chem; 1999 Oct; 274(41):28916-21. PubMed ID: 10506136
[TBL] [Abstract][Full Text] [Related]
55. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
Ng CP; Zisman A; Bonavida B
Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
[TBL] [Abstract][Full Text] [Related]
56. Sensitization by interleukin-6 of rat hepatocytes to tumor necrosis factor alpha-induced apoptosis.
Böer U; Fennekohl A; Püschel GP
J Hepatol; 2003 Jun; 38(6):728-35. PubMed ID: 12763364
[TBL] [Abstract][Full Text] [Related]
57. FGF induces a switch in death receptor pathways in neuronal cells.
Eves EM; Skoczylas C; Yoshida K; Alnemri ES; Rosner MR
J Neurosci; 2001 Jul; 21(14):4996-5006. PubMed ID: 11438575
[TBL] [Abstract][Full Text] [Related]
58. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
[TBL] [Abstract][Full Text] [Related]
59. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha.
Imamura R; Konaka K; Matsumoto N; Hasegawa M; Fukui M; Mukaida N; Kinoshita T; Suda T
J Biol Chem; 2004 Nov; 279(45):46415-23. PubMed ID: 15337758
[TBL] [Abstract][Full Text] [Related]
60. Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Sumida T; Nishioka K
Arthritis Rheum; 1999 Mar; 42(3):519-26. PubMed ID: 10088775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
